Evidence map›Paper›PMID 31330875›Full record

ArticleInternational journal of molecular sciences2019

Non-Cytotoxic Agarose/Hydroxyapatite Composite Scaffolds for Drug Release.

Markus Witzler, Patrick Frank Ottensmeyer, Martin Gericke, Thomas Heinze, Edda Tobiasch, Margit Schulze

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Exosomes: A New Hope for Angiogenesis-Mediated Bone Regeneration.International journal of molecular sciences · 2024
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Tooth Formation: Are the Hardest Tissues of Human Body Hard to Regenerate?International journal of molecular sciences · 2020
    Review
  17. Natural Polymeric Scaffolds in Bone Regeneration.Frontiers in bioengineering and biotechnology · 2020
    Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Markus WitzlerDepartment of Natural Sciences, Bonn-Rhein-Sieg University of Applied Sciences, von-Liebig-Str. 20, 53359 Rheinbach, Germany.ORCID 0000-0002-0468-3051
Patrick Frank OttensmeyerDepartment of Natural Sciences, Bonn-Rhein-Sieg University of Applied Sciences, von-Liebig-Str. 20, 53359 Rheinbach, Germany.
Martin GerickeInstitute of Organic Chemistry and Macromolecular Chemistry, Center of Excellence of Polysaccharide Research, Friedrich Schiller University of Jena, Humboldtstr. 10, 07743 Jena, Germany.ORCID 0000-0002-0273-1996
Thomas HeinzeInstitute of Organic Chemistry and Macromolecular Chemistry, Center of Excellence of Polysaccharide Research, Friedrich Schiller University of Jena, Humboldtstr. 10, 07743 Jena, Germany.
Edda TobiaschDepartment of Natural Sciences, Bonn-Rhein-Sieg University of Applied Sciences, von-Liebig-Str. 20, 53359 Rheinbach, Germany.
Margit SchulzeDepartment of Natural Sciences, Bonn-Rhein-Sieg University of Applied Sciences, von-Liebig-Str. 20, 53359 Rheinbach, Germany. margit.schulze@h-brs.de.ORCID 0000-0002-8975-1753

Funding

Bundesministerium für Forschung und Technologie 13FH019IX5Bundesministerium für Forschung und Technologie 13FH158IN6
6 · The paper itself

Abstract

Healing of large bone defects requires implants or scaffolds that provide structural guidance for cell growth, differentiation, and vascularization. In the present work, an agarose-hydroxyapatite composite scaffold was developed that acts not only as a 3D matrix, but also as a release system. Hydroxyapatite (HA) was incorporated into the agarose gels in situ in various ratios by a simple procedure consisting of precipitation, cooling, washing, and drying. The resulting gels were characterized regarding composition, porosity, mechanical properties, and biocompatibility. A pure phase of carbonated HA was identified in the scaffolds, which had pore sizes of up to several hundred micrometers. Mechanical testing revealed elastic moduli of up to 2.8 MPa for lyophilized composites. MTT testing on Lw35human mesenchymal stem cells (hMSCs) and osteosarcoma MG-63 cells proved the biocompatibility of the scaffolds. Furthermore, scaffolds were loaded with model drug compounds for guided hMSC differentiation. Different release kinetic models were evaluated for adenosine 5'-triphosphate (ATP) and suramin, and data showed a sustained release behavior over four days.

Indexed as

Tissue ScaffoldsBiocompatible MaterialsChemical PhenomenaDrug LiberationDurapatiteHumansMaterials TestingMechanical PhenomenaPorositySepharoseSpectrum AnalysisTissue EngineeringBiocompatible MaterialsDurapatiteSepharoseagarosebiocompositebone tissue engineeringdrug releasehydrogelhydroxyapatite

Identifiers

PMID31330875
PMCPMC6678963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.